Yingli Ma - Mar 15, 2024 Form 4/A Insider Report for Structure Therapeutics Inc. (GPCR)

Role
CHIEF TECHNOLOGY OFFICER
Signature
/s/ Jun Yoon, Attorney-in-Fact
Stock symbol
GPCR
Transactions as of
Mar 15, 2024
Transactions value $
$0
Form type
4/A
Date filed
3/20/2024, 07:39 PM
Date Of Original Report
Mar 19, 2024
Previous filing
Feb 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GPCR Stock Option (right to buy) Award $0 +91.5K $0.00 91.5K Mar 15, 2024 Ordinary Shares 91.5K $11.75 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correct the exercise price as that of the Ordinary Shares rather than the American Depositary Shares ("ADSs"). The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.
F2 1/4th of the shares subject to the option shall vest March 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.
F3 The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.